Adapting to Progress: Vorolanib Intravitreal Implant cover art

Adapting to Progress: Vorolanib Intravitreal Implant

Adapting to Progress: Vorolanib Intravitreal Implant

Listen for free

View show details

About this listen

 The pipeline for the treatment of wet age-related macular degeneration includes therapies that focus on new molecular targets. Carl J. Danzig, MD, FASRS, discusses a tyrosine kinase inhibitor. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to view more education? Click here.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.